Dexmedetomidine-Induced Sedation in Volunteers Decreases Regional and Global Cerebral Blood Flow
暂无分享,去创建一个
Leanne Groban | Frederic H Fahey | H. Gage | R. Prielipp | J. Butterworth | R. James | J. R. Tobin | F. Fahey | H Donald Gage | D. Stump | L. Groban | Richard C Prielipp | Michael H Wall | Joseph R Tobin | Mark A Cannon | David A Stump | Robert L James | Judy Bennett | John Butterworth | J. Bennett | M. Wall | Mark A. Cannon | Michael H. Wall | Joseph R. Tobin | Frederic H. Fahey | H. Donald Gage | David A. Stump | Robert L. James | David A. Stump
[1] B. K. Hartman,et al. Central noradrenergic regulation of cerebral blood flow and vascular permeability. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[2] C. Iadecola. Neurogenic control of the cerebral microcirculation: is dopamine minding the store? , 1998, Nature Neuroscience.
[3] R. Patterson,et al. The Minnesota impedance cardiograph- theory and applications. , 1974, Biomedical engineering.
[4] J. Kirsch,et al. α2-Adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent , 1994 .
[5] K. Minneman. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. , 1988, Pharmacological reviews.
[6] R A Koeppe,et al. Performance Comparison of Parameter Estimation Techniques for the Quantitation of Local Cerebral Blood Flow by Dynamic Positron Computed Tomography , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] Ulrich Dirnagl,et al. Optical Imaging of Brain Function and Metabolism 2 , 1997, Advances in Experimental Medicine and Biology.
[8] M. Maze,et al. Clinical Uses of ??2-Adrenergic Agonists: , 2000 .
[9] F. Prinzen,et al. The Effect of Dexmedetomidine on Nutrient Organ Blood Flow , 1996, Anesthesia and analgesia.
[10] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[11] M. Reivich,et al. ARTERIAL PCO2 AND CEREBRAL HEMODYNAMICS. , 1965, The American journal of physiology.
[12] D C Jeutter,et al. Determination of cardiac output using ensemble-averaged impedance cardiograms. , 1985, Journal of applied physiology.
[13] R. Weinshilboum,et al. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.
[14] W. K. Luk,et al. Adaptive, segmented attenuation correction for whole-body PET imaging , 1996 .
[15] F H Fahey,et al. Reduced Regional and Global Cerebral Blood Flow During Fenoldopam-Induced Hypotension in Volunteers , 2001, Anesthesia and analgesia.
[16] Judith E. Hall,et al. Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions , 2000, Anesthesia and analgesia.
[17] M. Raichle. Positron Emission Tomography with Oxygen-15 Radiopharmaceuticals , 1986 .
[18] M. Singer,et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit , 1999, Anaesthesia.
[19] R. M. Jones,et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. , 1999, British journal of anaesthesia.
[20] S. Sudikoff,et al. Techniques for measuring cerebral blood flow in children. , 1998, Current opinion in pediatrics.
[21] J. Kirsch,et al. α2-ADRENERGIC AGONIST EFFECTS ON NORMOCAPNIC AND HYPERCAPNIC CEREBRAL BLOOD FLOW IN THE DOG ARE ANESTHETIC-DEPENDENT , 1994 .
[22] H Iida,et al. Mechanisms of Dexmedetomidine-Induced Cerebrovascular Effects in Canine In Vivo Experiments , 1995, Anesthesia and analgesia.
[23] K. Herholz. Signal sources in PET. , 1997, Advances in experimental medicine and biology.
[24] Yuko Sato,et al. Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain , 1992, Neuroscience Research.
[25] Martin Reivich,et al. ARTERIAL PCO2 AND CEREBRAL HEMODYNAMICS. , 1964 .
[26] Clonidine-induced vasoconstriction in awake volunteers. , 2001, Anesthesia and analgesia.
[27] W. Bretz,et al. Red Marine Algae Lithothamnion calcareum Supports Dental Enamel Mineralization , 2023, Marine drugs.
[28] P. Talke,et al. Clonidine-Induced Vasoconstriction in Awake Volunteers , 2001, Anesthesia and analgesia.
[29] R. Koehler,et al. Intraventricular Dexmedetomidine Decreases Cerebral Blood Flow During Normoxia and Hypoxia in Dogs , 1997, Anesthesia and analgesia.
[30] M. Zornow,et al. Dexmedetomidine, an α2‐Adrenergic Agonist, Decreases Cerebral Blood Flow in the Isoflurane‐Anesthetized Dog , 1990, Anesthesia and analgesia.
[31] N. Toda. Alpha adrenergic receptor subtypes in human, monkey and dog cerebral arteries. , 1983, The Journal of pharmacology and experimental therapeutics.
[32] Judith E. Hall,et al. The Effects of Increasing Plasma Concentrations of Dexmedetomidine in Humans , 2000, Anesthesiology.